<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/"><channel><title>医学新闻</title><description>来自 News-Medical.Net - 来自世界各地的最新医学新闻和研究</description><link/>https://www.news-medical.net/<language> en-GB</language><item><title>地中海植物有望治疗心血管疾病</title><description>巴塞罗那自治大学最终学位项目发起的一项研究，由 INc-UAB、巴塞罗那大学以及古巴和智利机构的研究人员参与，对一组地中海植物进行了详尽的书目审查，其活性成分归因于对人群影响最大的心血管疾病领域的药理作用。</description><link/> https://www.news-medical.net/news/20241212/Mediterranean-plants-show-promise-for-cardiovian-disease-treatment.aspx<comments> https://www.news-medical.net/news/20241212/Mediterranean-plants-show-promise-for-cardioangio-disease-treatment.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=0e788731-e898-49ca-a330-c188ea6d65d9</guid><pubDate> Thu, 12 Dec 2024 11:21:00 -0500</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2014/7/Saffron-620x480.jpg" width="620"><media:description><![CDATA[Mediterranean plants show promise for cardiovascular disease treatment]]></media:description></media:content></item><item><title>欧盟心脏保护工作为心脏病患者带来新希望</title><description>心脏病发作是欧洲死亡和残疾的主要原因，其影响往往超出最初的事件范围，导致慢性心力衰竭。</description><link/> https://www.news-medical.net/news/20241212/EU-CARDIOPROTECTION-efforts-bring-new-hope-for-heart-attack-病人.aspx<comments> https://www.news-medical.net/news/20241212/EU-CARDIOPROTECTION-efforts-bring-new-hope-for-heart-attack-病人.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=48f3aa6f-2c68-4f71-ae4d-328c5e91a9df</guid><pubDate> Thu, 12 Dec 2024 11:11:40 -0500</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2014/9/heart_disease_1_12c3ff20f43b43d898bf18f5689e0c7c-620x480.jpg" width="620"><media:description><![CDATA[EU-CARDIOPROTECTION efforts bring new hope for heart attack patients]]></media:description></media:content></item><item><title>研究揭示移情反应背后的大脑机制</title><description>一种特定的大脑机制调节动物如何对他人的情绪做出同理心的反应。这是认知遗传学研究单位的最新发现，该单位由意大利理工学院（IIT - 意大利理工学院）首席研究员 Francesco Papaleo 领导，隶属于热那亚 IRCCS Ospedale Policlinico San Martino。</description><link/> https://www.news-medical.net/news/20241212/Study-uncovers-brain-mechanism-behind-empathetic-responses.aspx<comments> https://www.news-medical.net/news/20241212/Study-uncovers-brain-mechanism-behind-empathetic-responses.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=a87935d2-0068-460f-bb40-15acec297808</guid><pubDate> Thu, 12 Dec 2024 11:07:21 -0500</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2016/3/Artificially_Colored_MRI_Scan_Of_Human_Brain-Daisy_Daisy_a8c5d8bbbf824bc8932308e30187510f-620x480.jpg" width="620"><media:description><![CDATA[Study uncovers brain mechanism behind empathetic responses]]></media:description></media:content></item><item><title>胸壁照射不会影响中危乳腺癌的 10 年生存率</title><description>根据在圣安东尼奥乳腺癌会议上公布的 BIG 2-04 MRC SUPREMO 临床试验的结果，中危乳腺癌患者无论在乳房切除术后是否接受胸壁照射 (CWI)，其 10 年总生存率相似研讨会 (SABCS)，于 2024 年 12 月 10 日至 13 日举行。</description><link/> https://www.news-medical.net/news/20241212/Chest-wall-irradiation-does-not-impact-10-year-survival-in-intermediate-risk-breast-cancer.aspx<comments> https://www.news-medical.net/news/20241212/Chest-wall-irradiation-does-not-impact-10-year-survival-in-intermediate-risk-breast-cancer.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=d575604b-1f55-4de8-a672-a1aae8a83e46</guid><pubDate> Thu, 12 Dec 2024 10:57:26 -0500</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2014/7/91618146-620x480.jpg" width="620"><media:description><![CDATA[Chest wall irradiation does not impact 10-year survival in intermediate-risk breast cancer]]></media:description></media:content></item><item><title>低风险 DCIS 的主动监测可带来与标准治疗相似的生活质量</title><description>根据圣安东尼奥乳腺癌研讨会 (SABCS) 上公布的 COMET 临床试验结果，接受主动监测的低危导管原位癌 (DCIS) 患者的身体、情绪和心理结果与接受前期治疗的患者相当。 ），于2024年12月10日至13日举行。</description><link/> https://www.news-medical.net/news/20241212/Active-monitoring-for-low-risk-DCIS-results-in-similar-quality-of-life-as-standard-treatment.aspx<comments> https://www.news-medical.net/news/20241212/Active-monitoring-for-low-risk-DCIS-results-in-similar-quality-of-life-as-standard-treatment.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=003ff145-e7a4-4a69-aa60-7ec25f017ac5</guid><pubDate> Thu, 12 Dec 2024 09:43:34 -0500</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2016/2/Breast_Cancer_Mammogram_-_Tyler_Olsen_60b2170bc34146e8b8f10220c480f019-620x480.jpg" width="620"><media:description><![CDATA[Active monitoring for low-risk DCIS results in similar quality of life as standard treatment]]></media:description></media:content></item><item><title> COMET 试验显示，低风险 DCIS 的主动监测并不劣于标准治疗</title><description>在激素受体（HR）阳性、HER2阴性、低危导管原位癌（DCIS）患者中，接受主动监测的患者与接受指南一致治疗的患者的两年浸润性同侧乳腺癌复发率相似，根据 2024 年 12 月 10 日至 13 日举行的圣安东尼奥乳腺癌研讨会 (SABCS) 上公布的 COMET 临床试验结果。</description><link/> https://www.news-medical.net/news/20241212/COMET-trial-shows-active-monitoring-is-noninferior-to-standard-treatment-for-low-risk-DCIS.aspx<comments> https://www.news-medical.net/news/20241212/COMET-trial-shows-active-monitoring-is-noninferior-to-standard-treatment-for-low-risk-DCIS.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=ebefa2bc-378e-46e2-8c43-d36d69590d49</guid><pubDate> Thu, 12 Dec 2024 09:40:38 -0500</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2014/7/Carcinoma-620x480.jpg" width="620"><media:description><![CDATA[COMET trial shows active monitoring is noninferior to standard treatment for low-risk DCIS]]></media:description></media:content></item><item><title> PATINA 试验证明 Palbociclib 对 HR+ HER2+ 转移性乳腺癌的益处</title><description>Alliance Foundation Trials, LLC (AFT) 和辉瑞公司 (Pfizer Inc.) 今天公布了 III 期 PATINA 试验的结果，表明在当前标准护理一线维持治疗（诱导化疗后）中添加哌柏西利 (IBRANCE) 产生了统计学上的效果。通过研究者对激素受体阳性 (HR+)、人表皮生长因子受体 2 阳性 (HER2+) 转移性乳腺癌患者的评估，无进展生存期 (PFS) 显着且具有临床意义的改善（MBC）。</description><link/> https://www.news-medical.net/news/20241212/PATINA-trial-demonstrates-benefit-of-palbociclib-in-HR2b-HER22b-metastatic-breast-cancer.aspx<comments> https://www.news-medical.net/news/20241212/PATINA-trial-demonstrates-benefit-of-palbociclib-in-HR2b-HER22b-metastatic-breast-cancer.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=ea99b660-9609-4584-9616-230ddb991ccf</guid><pubDate> Thu, 12 Dec 2024 09:36:51 -0500</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2014/7/174318220-620x480.jpg" width="620"><media:description><![CDATA[PATINA trial demonstrates benefit of palbociclib in HR+ HER2+ metastatic breast cancer]]></media:description></media:content></item><item><title>他莫昔芬可降低高危 DCIS 患者的乳腺癌复发率</title><description>根据圣安东尼奥乳腺癌研讨会上公布的结果，对于接受保乳手术且未接受放疗的“高风险”导管原位癌 (DCIS) 患者，他莫昔芬显着降低了同一乳房复发的风险(SABCS)，于 2024 年 12 月 10 日至 13 日举行。</description><link/> https://www.news-medical.net/news/20241212/Tamoxifen-lowers-breast-cancer-recurrence-in-good-risk-DCIS-患者.aspx<comments> https://www.news-medical.net/news/20241212/Tamoxifen-lowers-breast-cancer-recurrence-in-good-risk-DCIS-患者.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=de133454-b1c4-42ea-a57c-c32d411a9271</guid><pubDate> Thu, 12 Dec 2024 09:33:15 -0500</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2014/7/Radiotherapy-620x480.jpg" width="620"><media:description><![CDATA[Tamoxifen lowers breast cancer recurrence in good-risk DCIS patients]]></media:description></media:content></item><item><title>研究将生命早期扁桃体切除与压力相关疾病的长期风险联系起来</title><description>研究人员探讨了扁桃体切除术和腺样体切除术与晚年患压力相关疾病的风险之间的潜在关联。</description><link/> https://www.news-medical.net/news/20241212/Study-links-early-life-tonsil-removal-to-long-term-risk-of-stress-lated-disorders.aspx<comments> https://www.news-medical.net/news/20241212/Study-links-early-life-tonsil-removal-to-long-term-risk-of-stress-lated-disorders.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=54f56d0d-3378-4a90-b875-07edd7514070</guid><pubDate> Thu, 12 Dec 2024 08:23:00 -0500</pubDate> <media:content expression="full" height="984" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/images/news/ImageForNews_798060_17339715673624699.jpg" width="2000"><media:description><![CDATA[Study links early-life tonsil removal to long-term risk of stress-related disorders]]></media:description></media:content></item><item><title>研究揭示了病毒进化的隐藏驱动因素，病毒每年导致 2000 万例感染</title><description>研究人员描述了啮齿动物中戊型肝炎病毒的进化起源。</description><link/> https://www.news-medical.net/news/20241212/Virus-causes-20-million-infections-annually-as-study-uncovers-hidden-drivers-of-its-evolution.aspx<comments> https://www.news-medical.net/news/20241212/Virus-causes-20-million-infections-annually-as-study-uncovers-hidden-drivers-of-its-evolution.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=f27ed43a-9d1d-4d64-8879-e3443e428e61</guid><pubDate> Thu, 12 Dec 2024 08:08:00 -0500</pubDate> <media:content expression="full" height="768" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/images/news/ImageForNews_798059_17339684544259036.jpg" width="1408"><media:description><![CDATA[Virus causes 20 million infections annually as study uncovers hidden drivers of its evolution]]></media:description></media:content></item></channel></rss>